sb.scorecardresearch
Advertisement

Published 19:58 IST, January 19th 2021

Russia's second COVID-19 vaccine EpiVacCorona '100% effective' in early trials: Report

Russia’s 2nd COVID vaccine candidate, EpiVacCorona, has proved to be 100% effective in early-stage trials, consumer health watchdog Rospotrebnadzor reported.

Reported by: Bhavya Sukheja
Follow: Google News Icon
  • share
Russia
null | Image: self
Advertisement

Loading...

19:58 IST, January 19th 2021